Related Articles
Luteinizing hormone-releasing hormone agonist triptorelin antagonizes signal transduction and mitogenic activity of epidermal growth factor in human ovarian and endometrial cancer cell lines
Targeting of doxorubicin to ES-2 human ovarian cancers in nude mice by linking to an analog of luteinizing hormone-releasing hormone improves its effectiveness
Targeted chemotherapy for triple-negative breast cancers via LHRH receptor
Luteinizing hormone-releasing hormone as an autocrine growth factor in ES-2 ovarian cancer cell line.
Effective targeted chemotherapy using AEZS-108 (AN-152) for LHRH receptor-positive pancreatic cancers